Flu Vaccinated Plasma
Flu Vaccinated Plasma - human plasma from donors with confirmed influenza vaccination history, processed within 24 hours. Ideal for hemagglutination inhibition (HAI) titer studies, vaccine platform comparison, and universal flu vaccine research targeting the conserved HA stalk domain. Stratification by vaccine type, strain formulation, and season.
Flu Vaccinated Plasma for Influenza Vaccine Immunogenicity Research
Our Flu Vaccinated Plasma is sourced from IRB-consented donors with a confirmed seasonal influenza vaccination history. Each sample is processed and frozen within 24 hours of collection to preserve circulating hemagglutinin-specific antibodies and cytokines for downstream vaccine immunogenicity research.
Flu Vaccination Biology and Why Plasma
- Influenza vaccines – inactivated, live-attenuated, and recombinant platforms – elicit antibody responses primarily targeting the hemagglutinin (HA) surface protein, with hemagglutination inhibition (HAI) titer serving as the gold-standard correlate of protection.
- Continuous antigenic drift in circulating influenza strains requires annual reformulation of vaccines, making strain-matched versus mismatched response data a key research variable each season.
- Plasma preserves coagulation factors and complement components alongside antibody titers, useful for studies spanning both immunogenicity and rare vaccine-associated adverse event research.
- Growing interest in universal influenza vaccines targeting the conserved HA stalk domain has increased demand for donor plasma that can distinguish strain-specific head-domain responses from broader stalk-directed immunity.
- Repeat annual vaccination history can shape subsequent responses through phenomena such as original antigenic sin, making vaccination history across multiple seasons a relevant donor variable.
Donor Stratification Available
- Vaccine type (inactivated, live-attenuated, recombinant, high-dose)
- Vaccination season and strain formulation
- Time since vaccination
- Vaccination history across multiple prior seasons
- Age band and sex assigned at birth
- Matched unvaccinated donors available on request
Product Features
- Collected from donors with confirmed seasonal influenza vaccination history
- Processed and frozen within 24 hours of collection
- Research Use Only (RUO)
- IRB-approved protocols with documented consent
- Standard and custom aliquot volumes available
De-identified Donor Data
- Vaccination confirmation, vaccine type, and season
- Age, sex assigned at birth, and ethnicity
- Donor-reported allergy and infectious disease history
- Prior vaccination history where documented
- Additional vaccination-specific metadata available on request
Applications
- Hemagglutination inhibition (HAI) and microneutralization titer studies
- Vaccine platform and strain-match comparison studies
- Universal influenza vaccine and HA stalk-antibody research
- Original antigenic sin and repeat-vaccination immune imprinting studies
- Serology assay development and validation
Other Flu Vaccinated Specimen Types
Compliance and Quality Assurance
- IRB-approved and HIPAA-compliant protocols
- Electronic informed consent with 21 CFR Part 11-compliant e-signatures
- Documentation support available for regulatory review
Ordering & Customization
Flu vaccinated plasma is available in standard and custom volumes. For pricing, international orders, or documentation requirements, please email learnmore@sanguinebio.com to ensure compatibility with your country’s regulations. To compare donor availability across conditions, visit our human plasma page.
Protocols & Documentation
-
Download
Plasma Isolation
Protocol for plasma separation from anticoagulated whole blood, including processing, storage, and traceability requirements.
-
Informed Consent Form (ICF)
Available upon request — confirms donor consent for research use and downstream commercialization.
Plasma
Frequently Asked Questions
1 Answer
YES – All collections are conducted under IRB-approved protocols and electronic informed consent. Sanguine utilizes Advarra and WCG IRB for oversight.
1 Answer
YES – all our products are research use only (RUO).
1 Answer
You can find our full product catalog here.
1 Answer
Storage depends on sample type but often cryopreserved samples stored in liquid nitrogen can be stored for years.
1 Answer
Extensive customization is available. To discuss your project request a quote or email us at learnmore@sanguinebio.com.
1 Answer
Sanguine offers flexible prospective collection services tailored to fit your research. For more information and to request a quote, please see: our prospective biospecimen collection services page.
1 Answer
Timelines depend on condition, sample type, and I/E criteria but we often start collection within 2 weeks of signed agreement.
1 Answer
YES – we have in-stock inventory. You can also email us at learnmore@sanguinebio.com as we continually get new samples in our inventory.
1 Answer
Each sample from a different individual – Unique donor means each sample comes from a different person, ensuring biological diversity in your study.
1 Answer
YES – Unique donors can be specified and guaranteed based on your requirements.
1 Answer
For information about sample quality, please see: Quality and Compliance
1 Answer
YES – “IRB-approved collection protocols” and IRB approval documentation available upon request. Sanguine utilizes two internationally-recognized IRBs (Advarra and WCG IRB) for review and approval.
Ask a Question
Need a custom Plasma cohort?
Our scientific team can scope prospective collections with donor-specific I/E criteria, typically starting within 2 weeks of agreement.